What does this research mean for the field?

Despite ongoing clinical trials exploring novel targets and repurposed drugs, there has been no breakthrough in the pharmacotherapy of chronic primary pain, largely due to inadequate preclinical models and high patient heterogeneity. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

November 14, 2025British Journal of Pharmacology

Novel approaches for drug development against chronic primary pain: A systematic review

View Full Paper

Ask AI

Bookmark

Authors

VTValéria Tékus ÉBÉva Borbély AGAndreas Göebel

Discussion

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Tékus et al. (2025) studied this question.

synapsesocial.com/papers/6a5bfa589ba431813273dadc https://doi.org/10.1111/bph.70228

View Full Paper

Ask AI

Bookmark

November 14, 2025British Journal of Pharmacology

Novel approaches for drug development against chronic primary pain: A systematic review

View Full Paper

Ask AI

Bookmark

Authors

VTValéria Tékus ÉBÉva Borbély AGAndreas Göebel

Discussion

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Tékus et al. (2025) studied this question.

synapsesocial.com/papers/6a5bfa589ba431813273dadc https://doi.org/10.1111/bph.70228

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark